PT  - JOURNAL ARTICLE
AU  - Buckely, Rita
ED  - Bredella, Miriam
TI  - GH Replacement Improves CV Risk Factors in Viscerally Obese Premenopausal Women
DP  - 2011 Sep 01
TA  - MD Conference Express
PG  - 11--12
VI  - 11
IP  - 5
4099  - http://mdc.sagepub.com/content/11/5/11.short
4100  - http://mdc.sagepub.com/content/11/5/11.full
AB  - Effects of Growth Hormone on Body Composition and Cardiovascular Risk Markers in Women with Visceral Adiposity was a 6-month randomized, double-blind, placebo-controlled trial to determine whether low-dose GH administration would reduce abdominal adiposity and CV risk markers in premenopausal women with reduced GH secretion due to abdominal obesity.